Factsheet – Joint Scientific Consultation for Medicinal Products (January 2025)
Under the Health Technology Assessement Regulation (EU) 2021/2028, Joint Scientific Consultation enables Health Technology Developers to exchange information on their development plans for a medicinal product or medical device and obtain guidance on the information, data, analyses and other evidence that are likely to be required from clinical studies for the Joint Clinical Assessment of those products.
Read the factsheet published by Directorate-General for Health and Food Safety on 10 January 2025.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (26 février 2025). Factsheet – Joint Scientific Consultation for Medicinal Products (January 2025). ELSIBI. Consulté le 25 avril 2025 à l’adresse https://doi.org/10.58079/13drx